Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
Samantha M OlsonMargaret M NewhamsNatasha B HalasaAshley M PriceJulie A BoomLeila C SahniPia S PannarajKatherine IrbyTracie C WalkerStephanie P SchwartzAline B MadduxElizabeth H MackTamara T BradfordJennifer E SchusterRyan A NofzigerMelissa A CameronKathleen ChiotosMelissa L CullimoreShira J GertzEmily R LevyMichele KongNatalie Z CvijanovichMary A StaatSatoshi KamidaniBrandon M ChataniSamina S BhumbraKatherine E BlineMary G GaspersCharlotte V HobbsSabrina M HeidemannMia MaamariHeidi R FloriJanet R HumeMatt S ZinterKelly N MichelsonLaura D ZambranoAngela P CampbellManish M PatelAdrienne G Randolphnull nullPublished in: The New England journal of medicine (2022)
Among hospitalized adolescent patients, two doses of the BNT162b2 vaccine were highly effective against Covid-19-related hospitalization and ICU admission or the receipt of life support. (Funded by the Centers for Disease Control and Prevention.).